Medpace Holdings Inc (MEDP)
307.63
-3.00
(-0.97%)
USD |
NASDAQ |
Nov 18, 12:44
Medpace Holdings Enterprise Value: 8.998B for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 8.998B |
| November 14, 2024 | 9.750B |
| November 13, 2024 | 10.59B |
| November 12, 2024 | 10.56B |
| November 11, 2024 | 10.64B |
| November 08, 2024 | 10.62B |
| November 07, 2024 | 10.33B |
| November 06, 2024 | 10.48B |
| November 05, 2024 | 9.545B |
| November 04, 2024 | 9.226B |
| November 01, 2024 | 9.276B |
| October 31, 2024 | 9.110B |
| October 30, 2024 | 9.238B |
| October 29, 2024 | 9.593B |
| October 28, 2024 | 9.580B |
| October 25, 2024 | 9.607B |
| October 24, 2024 | 9.540B |
| October 23, 2024 | 9.602B |
| October 22, 2024 | 9.492B |
| October 21, 2024 | 10.31B |
| October 18, 2024 | 10.42B |
| October 17, 2024 | 10.00B |
| October 16, 2024 | 10.11B |
| October 15, 2024 | 10.32B |
| October 14, 2024 | 10.33B |
| Date | Value |
|---|---|
| October 11, 2024 | 10.16B |
| October 10, 2024 | 10.06B |
| October 09, 2024 | 9.952B |
| October 08, 2024 | 9.854B |
| October 07, 2024 | 9.681B |
| October 04, 2024 | 10.01B |
| October 03, 2024 | 9.841B |
| October 02, 2024 | 9.814B |
| October 01, 2024 | 9.707B |
| September 30, 2024 | 9.718B |
| September 27, 2024 | 9.764B |
| September 26, 2024 | 9.604B |
| September 25, 2024 | 9.428B |
| September 24, 2024 | 10.52B |
| September 23, 2024 | 10.71B |
| September 20, 2024 | 10.83B |
| September 19, 2024 | 10.93B |
| September 18, 2024 | 10.69B |
| September 17, 2024 | 10.48B |
| September 16, 2024 | 10.55B |
| September 13, 2024 | 10.39B |
| September 12, 2024 | 10.18B |
| September 11, 2024 | 9.861B |
| September 10, 2024 | 9.651B |
| September 09, 2024 | 10.01B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.089B
Minimum
Mar 23 2020
13.67B
Maximum
Jul 16 2024
6.469B
Average
6.045B
Median
Jul 07 2021
Enterprise Value Benchmarks
| Globus Medical Inc | 10.79B |
| IQVIA Holdings Inc | 46.77B |
| Fortrea Holdings Inc | 2.754B |
| CEL-SCI Corp | 34.06M |
| AIM ImmunoTech Inc | 6.697M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 96.43M |
| Revenue (Quarterly) | 533.32M |
| Total Expenses (Quarterly) | 421.04M |
| EPS Diluted (Quarterly) | 3.01 |
| Gross Profit Margin (Quarterly) | 31.69% |
| Profit Margin (Quarterly) | 18.08% |
| Earnings Yield | 3.71% |
| Operating Earnings Yield | 4.15% |
| Normalized Earnings Yield | 3.712 |